Clinical Trials Directory

Trials / Completed

CompletedNCT02858024

A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

A Two-Cohort, Open-Label, Randomised, Three-Period Crossover Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
International Partnership for Microbicides, Inc. · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

A Two-Cohort, Open-Label, Randomised, Three-Period Crossover Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

Conditions

Interventions

TypeNameDescription
DRUGDapivirine Vaginal Ring-004 and no tamponsDapivirine Vaginal Ring-004 for 28 days, with menses, no tampon use (Treatment A),
DRUGDapivirine Vaginal Ring-004 with tamponsfollowed by Dapivirine Vaginal Ring-004 for 28 days, with menses, with tampon use (Treatment B)
DRUGDapivirine Vaginal Ring-004 with no mensesDapivirine Vaginal Ring-004 for 28 days, with no menses occurring (Treatment E; treatment period 3).
DRUGDapivirine Vaginal Ring-004 and same ring inserted after mensesDapivirine Vaginal Ring-004 used continuously until the start of menses, at which time the ring will be removed, and the same ring re-inserted five days later (estimated completion of menses) (Treatment C)
DRUGDapivirine Vaginal Ring-004 and new ring inserted after mensesDapivirine Vaginal Ring-004 used continuously until the start of menses, at which time the ring will be removed, and a new ring inserted five days later (estimated completion of menses) (Treatment D)

Timeline

Start date
2015-01-12
Primary completion
2016-04-16
Completion
2016-04-16
First posted
2016-08-08
Last updated
2017-09-06

Source: ClinicalTrials.gov record NCT02858024. Inclusion in this directory is not an endorsement.